Deucravacitinib in Plaque Psoriasis: Maintenance of Response Over 3 Years in the Phase 3 POETYK PSO-1 and PSO-2 Trials. J of Skin [Internet]. 2023 Nov. 13 [cited 2025 Nov. 3];7(6):s241. Available from: https://skin.dermsquared.com/skin/article/view/2360